| Feb 19, 2025 |
Feb 21, 2025 |
Solid Biosciences Inc.
|
10% Owner |
Buy |
100.0
|
+1,000,000
|
24.79%
|
✗
|
$4M |
| Jan 8, 2025 |
Jan 13, 2025 |
Olema Pharmaceuticals, Inc.
|
10% Owner |
Buy |
17.5
|
-3,200,000
|
-42.67%
|
✗
|
$1.7M |
| Feb 12, 2024 |
Feb 14, 2024 |
Kyverna Therapeutics, Inc.
|
10% Owner |
Buy |
100.0
|
+450,000
|
16.58%
|
✗
|
$9.9M |
| May 25, 2023 |
May 30, 2023 |
Annexon, Inc.
|
10% Owner |
Buy |
92.5
|
+300,000
|
5.55%
|
✗
|
$639.7K |
| Dec 8, 2021 |
Dec 10, 2021 |
Xilio Therapeutics, Inc.
|
10% Owner |
Buy |
85.0
|
+42,469
|
1.54%
|
✗
|
$410.2K |
| Jul 19, 2021 |
Jul 21, 2021 |
RAPID MICRO BIOSYSTEMS, INC.
|
10% Owner |
Buy |
87.5
|
+100,000
|
1.20%
|
✗
|
$2M |
| Jul 28, 2020 |
Jul 28, 2020 |
Annexon, Inc.
|
10% Owner |
Buy |
100.0
|
+400,000
|
14.08%
|
✗
|
$6.8M |
| Feb 4, 2020 |
Feb 6, 2020 |
Arcutis Biotherapeutics, Inc.
|
10% Owner |
Buy |
95.0
|
+294,117
|
7.98%
|
✗
|
$5M |
| Jul 24, 2018 |
Jul 26, 2018 |
Replimune Group, Inc.
|
10% Owner |
Buy |
100.0
|
+500,000
|
21.38%
|
✗
|
$7.5M |